| Evidence of sexual transmission of Zika virus E D’Ortenzio, S Matheron, X de Lamballerie, B Hubert, G Piorkowski, ... New England Journal of Medicine 374 (22), 2195-2198, 2016 | 816 | 2016 |
| The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study V Di Martino, P Rufat, N Boyer, P Renard, S Matheron, V Le Moing, ... Hepatology 34 (6), 1193-1199, 2001 | 422 | 2001 |
| No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception L Mandelbrot, R Tubiana, J Le Chenadec, C Dollfus, A Faye, E Pannier, ... Clinical Infectious Diseases 61 (11), 1715-1725, 2015 | 346 | 2015 |
| Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome: efficacy of long-term … C Leport, F Raffi, S Matheron, C Katlama, B Regnier, AG Saimot, ... The American journal of medicine 84 (1), 94-100, 1988 | 312 | 1988 |
| Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial JL Meynard, M Vray, L Morand-Joubert, E Race, D Descamps, G Peytavin, ... Aids 16 (5), 727-736, 2002 | 306 | 2002 |
| High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics E Ruppé, L Armand-Lefèvre, C Estellat, PH Consigny, A El Mniai, ... Clinical Infectious Diseases 61 (4), 593-600, 2015 | 291 | 2015 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 286 | 2005 |
| Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex E Dournon, W Rozenbaum, C Michon, C Perronne, P De Truchis, ... The Lancet 332 (8623), 1297-1302, 1988 | 260 | 1988 |
| Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification F Damond, M Worobey, P Campa, I Farfara, G Colin, S Matheron, ... AIDS research and human retroviruses 20 (6), 666-672, 2004 | 234 | 2004 |
| Cellular and plasma viral load in patients infected with HIV-2 F Simon, S Matheron, C Tamalet, I Loussert-Ajaka, S Bartczak, JM Pépin, ... Aids 7 (11), 1411-1418, 1993 | 222 | 1993 |
| Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome I Cochereau-Massin, P Lehoang, M Lautier-Frau, L Zazoun, P Marcel, ... Ophthalmology 98 (9), 1348-1355, 1991 | 205 | 1991 |
| Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, ... Clinical infectious diseases 58 (9), 1312-1321, 2014 | 195 | 2014 |
| Hiv-2 molecular epidemiology B Visseaux, F Damond, S Matheron, D Descamps, C Charpentier Infection, Genetics and Evolution 46, 233-240, 2016 | 184 | 2016 |
| Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus–1 transmission in France MJ Mayaux, JP Teglas, L Mandelbrot, A Berrebi, H Gallais, S Matheron, ... The Journal of pediatrics 131 (6), 857-862, 1997 | 160 | 1997 |
| Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections JC Melchior, G Raguin, A Boulier, E Bouvet, D Rigaud, S Matheron, ... The American journal of clinical nutrition 57 (5), 614-619, 1993 | 160 | 1993 |
| Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome P Lehoang, B Girard, M Robinet, P Marcel, L Zazoun, S Matheron, ... Ophthalmology 96 (6), 865-874, 1989 | 151 | 1989 |
| Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations L Musset, O Bouchaud, S Matheron, L Massias, J Le Bras Microbes and infection 8 (11), 2599-2604, 2006 | 149 | 2006 |
| HFRS after a wild rodent bit in the Haute-Savoie-and risk of exposure to Hantaan-like virus in a Paris laboratory. E Dournon, B Moriniere, S Matheron | 145 | 1984 |
| HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro B Roquebert, F Damond, G Collin, S Matheron, G Peytavin, A Benard, ... Journal of antimicrobial chemotherapy 62 (5), 914-920, 2008 | 142 | 2008 |
| In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors D Desbois, B Roquebert, G Peytavin, F Damond, G Collin, A Bénard, ... Antimicrobial agents and chemotherapy 52 (4), 1545-1548, 2008 | 141 | 2008 |
